Your browser doesn't support javascript.
loading
Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.
Jacobs, Ian J; Menon, Usha; Ryan, Andy; Gentry-Maharaj, Aleksandra; Burnell, Matthew; Kalsi, Jatinderpal K; Amso, Nazar N; Apostolidou, Sophia; Benjamin, Elizabeth; Cruickshank, Derek; Crump, Danielle N; Davies, Susan K; Dawnay, Anne; Dobbs, Stephen; Fletcher, Gwendolen; Ford, Jeremy; Godfrey, Keith; Gunu, Richard; Habib, Mariam; Hallett, Rachel; Herod, Jonathan; Jenkins, Howard; Karpinskyj, Chloe; Leeson, Simon; Lewis, Sara J; Liston, William R; Lopes, Alberto; Mould, Tim; Murdoch, John; Oram, David; Rabideau, Dustin J; Reynolds, Karina; Scott, Ian; Seif, Mourad W; Sharma, Aarti; Singh, Naveena; Taylor, Julie; Warburton, Fiona; Widschwendter, Martin; Williamson, Karin; Woolas, Robert; Fallowfield, Lesley; McGuire, Alistair J; Campbell, Stuart; Parmar, Mahesh; Skates, Steven J.
Affiliation
  • Jacobs IJ; Department of Women's Cancer, Institute for Women's Health, University College London, London, UK; University of New South Wales, Sydney, NSW, Australia; Centre for Women's Health, Institute of Human Development, University of Manchester, Manchester, UK. Electronic address: i.jacobs@unsw.edu.au.
  • Menon U; Department of Women's Cancer, Institute for Women's Health, University College London, London, UK. Electronic address: u.menon@ucl.ac.uk.
  • Ryan A; Department of Women's Cancer, Institute for Women's Health, University College London, London, UK.
  • Gentry-Maharaj A; Department of Women's Cancer, Institute for Women's Health, University College London, London, UK.
  • Burnell M; Department of Women's Cancer, Institute for Women's Health, University College London, London, UK.
  • Kalsi JK; Department of Women's Cancer, Institute for Women's Health, University College London, London, UK.
  • Amso NN; Obstetrics and Gynaecology, School of Medicine, College of Biomedical and Life Sciences, Cardiff University, Cardiff, UK.
  • Apostolidou S; Department of Women's Cancer, Institute for Women's Health, University College London, London, UK.
  • Benjamin E; Research Department of Pathology, Cancer Institute, University College London Hospital, London, UK.
  • Cruickshank D; Department of Gynaecological Oncology, James Cook University Hospital, Middlesbrough, UK.
  • Crump DN; Department of Women's Cancer, Institute for Women's Health, University College London, London, UK.
  • Davies SK; Department of Women's Cancer, Institute for Women's Health, University College London, London, UK.
  • Dawnay A; Clinical Biochemistry, University College London Hospital, London, UK.
  • Dobbs S; Department of Gynaecological Oncology, Belfast City Hospital, Belfast, UK.
  • Fletcher G; Department of Women's Cancer, Institute for Women's Health, University College London, London, UK.
  • Ford J; Department of Women's Cancer, Institute for Women's Health, University College London, London, UK; Malomatia (Information, Communication and Technology QATAR) Qatari Shareholding Company, Qatar.
  • Godfrey K; Northern Gynaecological Oncology Centre, Queen Elizabeth Hospital, Gateshead, Tyne and Wear, UK.
  • Gunu R; Department of Women's Cancer, Institute for Women's Health, University College London, London, UK.
  • Habib M; Department of Women's Cancer, Institute for Women's Health, University College London, London, UK; Medical Research Council Centre for Neuromuscular Diseases, National Hospital for Neurology and Neurosurgery, London, UK.
  • Hallett R; Department of Women's Cancer, Institute for Women's Health, University College London, London, UK; School of Medical Sciences, Bangor University, Bangor, Gwynedd, UK.
  • Herod J; Department of Gynaecology, Liverpool Women's Hospital, Liverpool, UK; Women's Hospital, Hamad Medical Corporation, Doha, Qatar.
  • Jenkins H; Department of Gynaecological Oncology, Royal Derby Hospital, Derby, UK.
  • Karpinskyj C; Department of Women's Cancer, Institute for Women's Health, University College London, London, UK.
  • Leeson S; Department of Gynaecological Oncology, Llandudno Hospital, Gwynedd, UK.
  • Lewis SJ; Department of Women's Cancer, Institute for Women's Health, University College London, London, UK.
  • Liston WR; Department of Women's Cancer, Institute for Women's Health, University College London, London, UK.
  • Lopes A; Northern Gynaecological Oncology Centre, Queen Elizabeth Hospital, Gateshead, Tyne and Wear, UK; Derriford Hospital, Plymouth, Devon, UK.
  • Mould T; Department of Gynaecological Oncology, University College London Hospital, London, UK; Department of Gynaecological Oncology, Royal Free Hospital, London.
  • Murdoch J; Department of Gynaecological Oncology, St Michael's Hospital, Bristol, UK.
  • Oram D; Department of Gynaecological Oncology, St Bartholomew's Hospital, London, UK.
  • Rabideau DJ; Biostatistics Center, Massachusetts General Hospital, Boston, MA, USA.
  • Reynolds K; Department of Gynaecological Oncology, St Bartholomew's Hospital, London, UK.
  • Scott I; Department of Gynaecological Oncology, Royal Derby Hospital, Derby, UK.
  • Seif MW; Central Manchester Foundation Trust, St Mary's Hospital, Manchester, UK; Institute of Cancer Sciences, University of Manchester, Manchester, UK.
  • Sharma A; Department of Women's Cancer, Institute for Women's Health, University College London, London, UK; Department of Gynaecological Oncology, University Hospital of Wales, Heath Park, Cardiff, UK.
  • Singh N; Department of Pathology, Barts Health National Health Service Trust, London, UK.
  • Taylor J; Department of Women's Cancer, Institute for Women's Health, University College London, London, UK.
  • Warburton F; Department of Women's Cancer, Institute for Women's Health, University College London, London, UK; Public Health England, London, UK.
  • Widschwendter M; Department of Women's Cancer, Institute for Women's Health, University College London, London, UK.
  • Williamson K; Department of Gynaecological Oncology, Nottingham City Hospital, Nottingham, UK.
  • Woolas R; Department of Women's Cancer, Institute for Women's Health, University College London, London, UK; Department of Gynaecological Oncology, Queen Alexandra Hospital, Portsmouth, Hampshire, UK.
  • Fallowfield L; Sussex Health Outcomes Research and Education in Cancer, Brighton and Sussex Medical School, University of Sussex, Sussex, UK.
  • McGuire AJ; Department of Social Policy, London School of Economics, London, UK.
  • Campbell S; Create Health Clinic, London, UK.
  • Parmar M; Medical Research Council Clinical Trials Unit at University College London, London, UK.
  • Skates SJ; Biostatistics Center, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
Lancet ; 387(10022): 945-956, 2016 Mar 05.
Article in En | MEDLINE | ID: mdl-26707054
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Early Detection of Cancer Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies / Screening_studies Limits: Aged / Female / Humans / Middle aged Country/Region as subject: Europa Language: En Journal: Lancet Year: 2016 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Early Detection of Cancer Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies / Screening_studies Limits: Aged / Female / Humans / Middle aged Country/Region as subject: Europa Language: En Journal: Lancet Year: 2016 Document type: Article